Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls.

[1]  M. Morrow,et al.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Monica Morrow,et al.  Locoregional treatment of primary breast cancer , 2010, Cancer.

[3]  J. de Bresser,et al.  Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  M. Morrow,et al.  Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy (CPM). , 2009 .

[5]  R. Aft,et al.  The impact of breast MRI on surgical decision‐making: Are patients at risk for mastectomy? , 2009, Journal of surgical oncology.

[6]  R. Warren,et al.  Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. O'toole,et al.  Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Nabil Wasif,et al.  MRI versus Ultrasonography and Mammography for Preoperative Assessment of Breast Cancer , 2009, The American surgeon.

[9]  M. Morrow,et al.  Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. , 2009, Journal of the American College of Surgeons.

[10]  D. McCready,et al.  Magnetic Resonance Imaging in the Planning of Initial Lumpectomy for Invasive Breast Carcinoma: Its Effect on Ipsilateral Breast Tumor Recurrence After Breast-Conservation Therapy , 2009, Annals of Surgical Oncology.

[11]  J. Peterse,et al.  The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study , 2009, Breast Cancer Research and Treatment.

[12]  J. Costantino,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Peter Bult,et al.  Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component , 2009, BMC Medical Imaging.

[14]  E. Beckjord,et al.  Diagnostic Breast Magnetic Resonance Imaging and Contralateral Prophylactic Mastectomy , 2009, Annals of Surgical Oncology.

[15]  P. Drew,et al.  The UK NIHR multicentre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer. , 2009 .

[16]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Barbara L. Smith,et al.  Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.

[19]  F. B. Sørensen,et al.  Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Cho,et al.  Factors Associated with Negative Margins of Lumpectomy Specimen: Potential Use in Selecting Patients for Intraoperative Radiotherapy , 2008, Annals of surgical oncology.

[21]  M. Schnall,et al.  Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Shin,et al.  Breast MRI for Evaluating Patients with Metastatic Axillary Lymph Node and Initially Negative Mammography and Sonography , 2007, Korean journal of radiology.

[23]  Simone Schrading,et al.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.

[24]  Kjell Arne Kvistad,et al.  Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. , 2007, Breast.

[25]  P. Parizel,et al.  MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. , 2007, European journal of radiology.

[26]  C. Gatsonis,et al.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.

[27]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[28]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[29]  E. Morris,et al.  Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia , 2007, Annals of Surgical Oncology.

[30]  D. Scholtens,et al.  Selecting patients for breast‐conserving therapy , 2006, Cancer.

[31]  C. Geyer,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[33]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[35]  C. D'Orsi,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.

[36]  E. Morris,et al.  Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer , 2005, Annals of Surgical Oncology.

[37]  K. McMahon,et al.  Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin. , 2005, Australasian radiology.

[38]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[39]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[40]  Darrell N. Smith,et al.  Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. , 2005, International journal of radiation oncology, biology, physics.

[41]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[42]  Massimo Bazzocchi,et al.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.

[43]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[44]  F. Vicini,et al.  Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast‐conserving therapy at a single institution , 2004, Cancer.

[45]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[46]  Uwe Fischer,et al.  The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.

[47]  B. Goh,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2004, Cancer.

[48]  B. Emami,et al.  Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. , 2003, International journal of radiation oncology, biology, physics.

[49]  J. Hendriks,et al.  Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.

[50]  Elizabeth A Morris,et al.  MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.

[51]  J. Klijn,et al.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[53]  J. Olson,et al.  Magnetic Resonance Imaging Facilitates Breast Conservation for Occult Breast Cancer , 2000, Annals of Surgical Oncology.

[54]  S. Harms,et al.  Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. , 1999, American journal of surgery.

[55]  U. Veronesi,et al.  Conservative methods for breast cancer of small size: the experience of the National Cancer Institute, Milan (1973-1998). , 1999, Breast.

[56]  D. Fraker,et al.  Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. , 1999, Radiology.

[57]  J. Coebergh,et al.  Local recurrence after breast conservation therapy for early stage breast carcinoma , 1999 .

[58]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[59]  A. Rademaker,et al.  Medical contraindications are not a major factor in the underutilization of breast conserving therapy. , 1998, Journal of the American College of Surgeons.

[60]  I. Gage,et al.  Skin recurrences after breast-conserving therapy for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  L. Schwartz,et al.  MR imaging of the breast in patients with occult primary breast carcinoma. , 1997, Radiology.

[62]  H. Cody.  Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993. , 1997, Annals of surgery.

[63]  R. Schmidt,et al.  Patient selection for breast conservation therapy with magnification mammography. , 1995, Surgery.

[64]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[65]  C. Redmond,et al.  Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. , 1992, Seminars in surgical oncology.

[66]  F. Holmes,et al.  Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin , 1990, Cancer.

[67]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[68]  M. Kemeny,et al.  Occult primary adenocarcinoma with axillary metastases. , 1986, American journal of surgery.

[69]  P. Pressman.  Selective biopsy of the opposite breast , 1986, Cancer.

[70]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[71]  S. Feig,et al.  Multicentricity of non‐palpable breast cancer , 1980, Cancer.

[72]  M. Lagios.  Multicentricity of breast carcinoma demonstrated by routine correlated serial multicentric breast carcinoma subgross and radiographic examination , 1977, Cancer.

[73]  F. Rosato,et al.  Diseases of the Breast , 1972 .

[74]  C. Cox,et al.  Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer , 2010 .

[75]  T. King,et al.  Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging , 2010 .

[76]  P. Bult,et al.  The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast , 2009, Breast Cancer Research and Treatment.

[77]  Bernard Verbeeten Instituut.  Using loco-regional recurrence as an indicator of the quality of breast cancer treatment , 2004 .

[78]  J. Peterse,et al.  Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. , 1999, European journal of cancer.

[79]  A. Fortin,et al.  Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  J. Coebergh,et al.  Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). , 1999, Cancer.

[81]  K. Kerlikowske,et al.  Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. , 1997, Journal of the National Cancer Institute. Monographs.

[82]  C. Bressac,et al.  Is breast conservation after local recurrence feasible? , 1991, European journal of cancer.

[83]  M. Lagios.  Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. , 1977, Cancer.